Related Experiment Videos
Apoptosis: letting slip the dogs of war
1Department of Cellular Immunology, La Jolla Institute for Allergy and Immunology, 10355 Science Center Drive, San Diego, California 92121, USA.
Current Biology : CB
|March 8, 2002
Abstract:
Recent studies have shown that, during cell death, the protein Omi is released from the mitochondrial intermembrane space into the cytosol, where it augments caspase-dependent apoptosis by blocking inhibitors and may induce caspase-independent cell death via its serine protease activity.
Insights
The protein Omi, released during cell death, enhances apoptosis by inhibiting cell death blockers and can also trigger caspase-independent cell death through its protease activity.
Area of Science:
- Biochemistry
- Molecular Biology
- Cell Biology
Background:
- Cell death pathways are crucial for organismal development and homeostasis.
- Mitochondria play a central role in regulating cell death.
- The protein Omi's localization and function during apoptosis are under investigation.
Purpose of the Study:
- To elucidate the role of the mitochondrial protein Omi in apoptosis.
- To investigate Omi's mechanism in both caspase-dependent and caspase-independent cell death.
- To understand Omi's function in the cytosol following its release from mitochondria.
Main Methods:
- Studies involving protein localization analysis during cell death.
- Assays to determine Omi's effect on caspase activity.
- Biochemical analyses to assess Omi's serine protease function.
Main Results:
- Omi is released from the mitochondrial intermembrane space into the cytosol during cell death.
- Cytosolic Omi augments caspase-dependent apoptosis by inhibiting caspase inhibitors.
- Omi exhibits serine protease activity that may induce caspase-independent cell death.
Conclusions:
- Omi acts as a key regulator of apoptosis through multiple mechanisms.
- Omi's dual role in both caspase-dependent and independent pathways highlights its significance in cell death.
- Understanding Omi's function provides insights into therapeutic strategies for diseases involving aberrant cell death.